IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma? Plus, we explore the crucial role of patient-reported outcomes in healthcare delivery and examine ...

Since December 2022, and COP decision 15/9, members of the Convention on Biological Diversity (the CBD) have been negotiating a multilateral mechanism for the fair and equitable sharing of benefits ...